BackMolecular Pharmacology (USA), Overview

Molecular Pharmacology (USA), Total Assets

Latest total assets for MLPH: $8.8K.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$8844.00
↓ 30.37% YoYΔ $-3858.00 vs prior year quarter

Peer trimmed avg / median

Loading

Molecular Pharmacology (USA), Total Assets History

Loading

Molecular Pharmacology (USA), vs. peers: Total Assets Comparison

Loading

Molecular Pharmacology (USA), Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecular Pharmacology (USA), (MLPH) FAQ

Molecular Pharmacology (USA), posts a total assets of $8.8K as of September 2014. That compares with $13K in the prior-year period — down 30.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Molecular Pharmacology (USA),'s total assets was $13K. The latest reading is $8.8K — a 30.4% year-over-year decrease (period ending September 2014). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Molecular Pharmacology (USA),'s financial statement story. At $8.8K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MLPH's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Molecular Pharmacology (USA),'s other metric pages and overview cover the third.